20 Parkinsons Disease Clinical Trials in San Francisco, CA (2026)

Q: How do I join a clinical trial in San Francisco?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you.

Recruiting Parkinsons Disease Studies in San Francisco

NCT05065060Recruiting

Parkinson Progression Marker Initiative Online (PPMI Online)

Parkinson Progression Marker Initiative Online (PPMI Online) is an observational study collecting participant reported information from people with and without Parkinson's disease (PD), for the goal o...

San Francisco, CA500,000 participantsMichael J. Fox Foundation for Parkinson's Research

View Study Details

NCT04994015Recruiting

Parkinson's Foundation PD GENEration Genetic Registry

Development of a central repository for PD-related genomic data for future research....

San Francisco, CA25,000 participantsParkinson's Foundation

View Study Details

NCT03664609Recruiting

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records....

San Francisco, CA5,000 participantsBoston Scientific Corporation

View Study Details

NCT04477785Recruiting

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biolo...

San Francisco, CA4,500 participantsMichael J. Fox Foundation for Parkinson's Research

View Study Details

NCT05033990Recruiting

SPIROMICS Study of Early COPD Progression (SOURCE)

This is an observational study of 1000 participants to further define the nature of early chronic obstructive pulmonary disease (COPD) in younger, at-risk individuals. The study has three main goals:...

San Francisco, CA1,000 participantsUniversity of Massachusetts, Worcester

View Study Details

NCT07174310Recruiting

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with early-stage Parkinson's disease (PD) on stable sympt...

San Francisco, CAPHASE3900 participantsHoffmann-La Roche

View Study Details

NCT05572632Recruiting

Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD

Chronic obstructive pulmonary disease (COPD), one of the leading causes of death in the US, disproportionately affects low socioeconomic communities. While few interventions effectively modify the cou...

San Francisco, CANA387 participantsUniversity of California, San Francisco

View Study Details

NCT04373317Recruiting

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Patients with Parkinson's disease (PD) sometimes experience symptoms affecting their movement, such as slowness, tremor, stiffness, and balance or walking problems. Many patients also have other sympt...

San Francisco, CAPHASE4358 participantsVA Office of Research and Development

View Study Details

NCT07059091Recruiting

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

This research is being done to test if a drug called omalizumab can help people with Chronic Obstructive Pulmonary Disease (COPD) and allergies. Each participant will be in the study for about 16 mon...

San Francisco, CAPHASE2334 participantsJohns Hopkins University

View Study Details

NCT06285643Recruiting

A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson'...

San Francisco, CAPHASE2127 participantsAskBio Inc

View Study Details

NCT06231563Recruiting

Ketamine for Veterans With Parkinson's Disease

Parkinson's disease (PD) is a devastating illness that has a growing impact on Veterans. One of the most disabling symptoms is depression, which is common in PD and linked to poor quality of life and ...

San Francisco, CAPHASE280 participantsVA Office of Research and Development

View Study Details

NCT05065151Recruiting

Understanding Motivation in Parkinson's Patients Through Neurophysiology

The study aims to better understand motivation and value-based decision-making in Parkinson's patients through neurophysiology using Medtronic's Percept DBS device. By combining behavioral tasks with ...

San Francisco, CANA70 participantsUniversity of California, San Francisco

View Study Details

NCT06455293Recruiting

Psilocybin Therapy for Depression in Parkinson's Disease

The purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy....

San Francisco, CAPHASE260 participantsJoshua Woolley, MD, PhD

View Study Details

NCT06610877Recruiting

Ultrasound Neuromodulation in Essential Tremor

This study is being done to test whether low-intensity focused ultrasound (LIFU) (low energy sound waves) cause temporary changes in brain activity and behavior when directed at particular parts of th...

San Francisco, CANA60 participantsUniversity of California, San Francisco

View Study Details

NCT07119229Recruiting

A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

A study taking place at multiple sites in the United States, Europe and Brazil to evaluate how well a new therapy for severe COPD/emphysema works, and how safe it is....

San Francisco, CANA60 participantsPulmair Medical, Inc.

View Study Details

NCT07682311Recruiting

Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator

Parkinson's disease (PD) affects \~1% of people over 60 years old, is highly disabling and represents a large economic burden. While dopaminergic medications effectively treat motor symptoms early in ...

San Francisco, CANA40 participantsUniversity of California, San Francisco

View Study Details

NCT04722835Recruiting

Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers

Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disease that affects only a fraction of those who smoke tobacco. The origin of this variability in susceptibility to develop COPD is unc...

San Francisco, CA40 participantsUniversity of California, San Francisco

View Study Details

NCT07554833Recruiting

Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's Disease

Parkinson's disease (PD) is a brain disorder that causes progressive problems with movement, such as slowness, stiffness, tremor, and difficulty walking. Many people with PD also develop problems with...

San Francisco, CANA40 participantsSan Francisco Neurology and Sleep Center

View Study Details

NCT07398157Recruiting

Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease

The purpose of this study is to test a new way to treat Parkinson's disease (PD). Subjects will be implanted with deep brain stimulator (DBS) devices and electrodes placed under the scalp. The main q...

San Francisco, CANA24 participantsUniversity of California, San Francisco

View Study Details

NCT07284823Recruiting

Safety and Usability of the Cionic Neural Sleeve for Parkinson's Disease

This research will investigate the safety and usability of the Cionic Neural Sleeve Multistim System for Parkinson's Disease....

San Francisco, CANA10 participantsCionic, Inc.

View Study Details

About Parkinsons Disease Clinical Trials in San Francisco

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 20 parkinsons disease clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 538,090 participants. Research is being sponsored by Michael J. Fox Foundation for Parkinson's Research, Parkinson's Foundation, Boston Scientific Corporation and 10 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in San Francisco — FAQ

Are there parkinsons disease clinical trials in San Francisco?

Yes, there are 20 parkinsons disease clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 20 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated July 18, 2026 from ClinicalTrials.gov